Simplifying medication regimes may be recommended to improve adherence (Grade C, Evidence level IV) Simplifying medication regimes may be recommended to improve adherence (Grade C, Evidence level IV) Simplifying medication regimes may be recommended to improve adherence (Grade C, Evidence level IV)
Strength of recommendation: Weak recommendation with evidence coming from a single study involving participants with asthma from 22 years of age.27 Other considerations: Evidence comes from the use of combined corticosteroid and long-acting bronchodilator inhalers for asthma but is likely to be generalizable. If possible use the same inhaler system for all inhaled medications for the same patient and if possible restrict to once daily. References: Axelsson27.
Medication reminders, mobile applications and web-based applications, monitors or routines can be recommended to improve adherence, symptom control and quality of life (Grade B, Evidence level I-IV) Medication reminders, mobile applications and web-based applications, monitors or routines can be recommended to improve adherence, symptom control and quality of life (Grade B, Evidence level I-IV) Medication reminders, mobile applications and web-based applications, monitors or routines can be recommended to improve adherence, symptom control and quality of life (Grade B, Evidence level I-IV)
Strength of recommendation: Weak recommendation for smartphone- based health applications, medication reminders or monitors as only suggested by qualitative studies.35,36,38 Recommendation for the use of a specific web-application (MyMediHealthApp) is moderate since efficacy proven by a controlled trial.34
Other considerations: A smartphone-based personalized health app, medication reminders or monitors were suggested in qualitative studies. All studies focused on asthma but likely to be also applicable to allergy.
References: Naimi35, Blaakman36, Koster38, Johnson34.